Market Snapshot
S&P Futures
3,914.75
Dow Futures
31,478
Nasdaq Futures
12,132.75
Abbott Laboratories
(NYSE:ABT)
$106.21
$0.77
0.73%
Abbott Laboratories Chart
ABT Stock Price Today
Abbott Laboratories (ABT) stock rallied over 0.73% intraday to trade at $106.21 a share on NYSE. The stock opened with a gain of 2.57% at $105.95 and touched an intraday high of $106.78, rising 0.73% against the last close of $105.44. The stock went to a low of $105.07 during the session.
Stock Snapshot
$105.44
Prev. Close
185.13 Billion
Market Cap
$105.07
Day Low
$105.95
Open
1.76 Billion
Number of Shares
$106.78
Day High
24.52
P/E ratio
4.33
EPS (TTM)
5.81
Cash Flow per Share
0.79
Free Float in %
19.47
Book Value
5,059,583
Volume
Abbott Laboratories Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-06-23 | $105.95 | $106.78 | $105.07 | $106.21 | 5,064,800 |
| 2022-06-22 | $103.55 | $106.58 | $103.29 | $105.44 | 5,511,600 |
| 2022-06-21 | $104.86 | $104.95 | $103.33 | $104.41 | 5,338,300 |
| 2022-06-17 | $101.24 | $103.69 | $101.24 | $102.53 | 10,176,500 |
| 2022-06-16 | $102.4 | $102.75 | $101.24 | $102.07 | 4,793,600 |
| 2022-06-15 | $104.32 | $106.08 | $102.66 | $104.8 | 5,278,100 |
| 2022-06-14 | $105.1 | $105.4 | $101.95 | $102.94 | 5,890,100 |
| 2022-06-13 | $107.68 | $108.1 | $105.34 | $105.91 | 5,215,300 |
| 2022-06-10 | $110.81 | $111.48 | $109.1 | $109.63 | 4,805,600 |
| 2022-06-09 | $114.64 | $115.44 | $112.68 | $112.71 | 3,424,700 |
Contact Details
Company Information
Employees-
Beta0.77
Sales or Revenue44.51 Billion
5Y Sales Change15.60%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Equipment
About Company
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Frequently Asked Questions
What is the current Abbott Laboratories (ABT) stock price?
Abbott Laboratories (NYSE: ABT) stock price is $106.21 as of the last check on Thursday, June 23. During the trading session, ABT stock reached the peak price of $106.78 while $105.07 was the lowest point it dropped to.
ABT's industry and sector of operation?
The NYSE listed ABT is part of Health Care Equipment industry that operates in the broader Health Care sector. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Who are the executives of ABT?
Mr. Robert B. Ford
Chairman, Pres & CEO
Mr. Robert E. Funck Jr.
Exec. VP of Fin. & CFO
Mr. Hubert L. Allen
Exec. VP, Gen. Counsel & Sec.
Mr. Daniel Gesua Sive Salvadori
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
What is the ABT stock price today?
ABT stock traded closed the last session at $106.21, which is $0.77 or 0.73% lower than its previous close of $105.44. ABT's current trading price is 4.91% lower than its 52-week high of $142.60 where as its distance from 52-week low of 101.24% is -25.52%.
How many employees does ABT have?
Number of ABT employees currently stands at -. ABT operates from 100 Abbott Park Road, Abbott Park, North Chicago, IL 60064-6400, United States.
Link for ABT official website?
Official Webiste of $ABT is: https://www.abbott.com
How do I contact ABT?
ABT could be contacted at ABT operates from 100 Abbott Park Road, Abbott Park, North Chicago, IL 60064-6400, United States, or at phone #224 667 6100 and can also be accessed through its website.
How many shares of ABT are traded daily?
ABT stock volume for the day was 5,059,583 shares while in the previous session number of ABT shares traded was 5,064,800 . The average number of ABT shares traded daily for last 3 months was 5.33 Million.
How much did ABT change today?
The percentage change in ABT stock occurred in the recent session was 0.73% while the dollar amount for the price change in ABT stock was $0.77.
What price range ABT stock been trading in?
In the recent session, the day high for ABT stock was $106.78 while the low for ABT stock touched on the day was $105.07.
What is the market cap of ABT currently?
The market value of ABT currently stands at 185.13 Billion with its latest stock price at $106.21 and 1.76 Billion of its shares outstanding.